Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0Q4YI
|
|||
Former ID |
DIB015290
|
|||
Drug Name |
Trimetazidine
|
|||
Synonyms |
Trimetazidine dihydrochloride; 13171-25-0; 1-(2,3,4-Trimethoxybenzyl)piperazine dihydrochloride; Kyurinett; Trimetazidine hydrochloride; Trimetajust; Lubomail; Yosimilon; Vastarel; Trimetazidine HCl; Trimetazidine (dihydrochloride); 1-[(2,3,4-trimethoxyphenyl)methyl]piperazine dihydrochloride; Trimetazidine DiHCl; UNII-48V6723Z1P; EINECS 236-117-0; S 4004; 48V6723Z1P; Piperazine, 1-[(2,3,4-trimethoxyphenyl)methyl]-, dihydrochloride; DSSTox_RID_80858; DSSTox_CID_25407; DSSTox_GSID_45407; W-108326; Piperazine, 1-(2,3,4-trimethoxyb
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Angina pectoris [ICD-11: BA40; ICD-9: 413] | Approved | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C14H22N2O3
|
|||
Canonical SMILES |
COC1=C(C(=C(C=C1)CN2CCNCC2)OC)OC
|
|||
InChI |
1S/C14H22N2O3/c1-17-12-5-4-11(13(18-2)14(12)19-3)10-16-8-6-15-7-9-16/h4-5,15H,6-10H2,1-3H3
|
|||
InChIKey |
UHWVSEOVJBQKBE-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 5011-34-7
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:94789
|
Interaction between the Drug and Microbe | Top | |||
---|---|---|---|---|
The Metabolism of Drug Affected by Studied Microbe(s) | ||||
The Order in the Taxonomic Hierarchy of the following Microbe(s): Bacteroidales | ||||
Studied Microbe: Bacteroides fragilis str. 3397 T10
Show/Hide Hierarchy
|
[2] | |||
Hierarchy | ||||
Experimental Method | High-throughput screening | |||
Description | Trimetazidine dihydrochloride can be metabolized by Bacteroides fragilis str. 3397 T10 (log2FC = -0.72; p = 0.013). |
References | Top | |||
---|---|---|---|---|
REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
REF 2 | Mapping human microbiome drug metabolism by gut bacteria and their genes. Nature. 2019 Jun;570(7762):462-467. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.